Not currently recruiting at UCSD
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jeannie Huang
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Jeannie Huang
Dr. Jeannie Huang is Professor of Pediatrics at UC San Diego School of Medicine and Medical Director of the Inflammatory Bowel Disease Center at Rady Children's Hospital-San Diego. She is also a Physician Informaticist, Director of Continuing Medical Education at Rady Children's and Assistant Dean of Continuing Medical Education at UC San Diego.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease (AMAY)
- ID
- NCT05509777
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 90 study participants
- Last Updated